avrg: GSE58827: Dynamics of the Mouse Liver
Name | miRBASE accession |
---|---|
mmu-let-7a-5p
|
MIMAT0000521 |
mmu-let-7b-5p
|
MIMAT0000522 |
mmu-let-7c-5p
|
MIMAT0000523 |
mmu-let-7d-5p
|
MIMAT0000383 |
mmu-let-7e-5p
|
MIMAT0000524 |
mmu-let-7f-5p
|
MIMAT0000525 |
mmu-let-7g-5p
|
MIMAT0000121 |
mmu-let-7i-5p
|
MIMAT0000122 |
mmu-let-7k
|
MIMAT0025580 |
mmu-miR-98-5p
|
MIMAT0000545 |
mmu-miR-1961
|
MIMAT0009434 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.7 | 8.1 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
1.4 | 4.1 | GO:0098928 | presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
1.3 | 6.3 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
1.1 | 5.4 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
1.1 | 9.7 | GO:0010587 | miRNA catabolic process(GO:0010587) |
1.0 | 2.9 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.9 | 3.7 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.9 | 3.6 | GO:0051586 | positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.9 | 3.6 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.8 | 3.2 | GO:1903943 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
0.7 | 5.2 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.7 | 2.7 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.7 | 2.0 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.6 | 1.9 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.6 | 1.7 | GO:0007521 | muscle cell fate determination(GO:0007521) |
0.5 | 1.6 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
0.5 | 2.7 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.5 | 2.1 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.5 | 3.1 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.5 | 1.5 | GO:0045976 | negative regulation of mitotic cell cycle, embryonic(GO:0045976) |
0.5 | 2.0 | GO:0030167 | proteoglycan catabolic process(GO:0030167) regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.5 | 1.8 | GO:0003347 | epicardial cell to mesenchymal cell transition(GO:0003347) |
0.4 | 1.7 | GO:1902943 | regulation of voltage-gated chloride channel activity(GO:1902941) positive regulation of voltage-gated chloride channel activity(GO:1902943) positive regulation of gastro-intestinal system smooth muscle contraction(GO:1904306) |
0.4 | 3.3 | GO:0015919 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.4 | 1.2 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.4 | 1.2 | GO:1990168 | protein K27-linked deubiquitination(GO:1990167) protein K33-linked deubiquitination(GO:1990168) |
0.4 | 1.2 | GO:1990523 | bone regeneration(GO:1990523) |
0.4 | 2.0 | GO:0015867 | ATP transport(GO:0015867) |
0.4 | 1.1 | GO:0006601 | creatine biosynthetic process(GO:0006601) |
0.3 | 1.0 | GO:0003218 | cardiac left ventricle formation(GO:0003218) |
0.3 | 2.6 | GO:0015074 | DNA integration(GO:0015074) |
0.3 | 0.9 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.3 | 0.9 | GO:1900739 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.3 | 1.5 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
0.3 | 0.9 | GO:0010615 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
0.3 | 0.9 | GO:0033082 | regulation of extrathymic T cell differentiation(GO:0033082) |
0.3 | 1.1 | GO:0046898 | response to cycloheximide(GO:0046898) |
0.3 | 5.1 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.3 | 0.8 | GO:0034147 | regulation of granuloma formation(GO:0002631) negative regulation of granuloma formation(GO:0002632) regulation of toll-like receptor 5 signaling pathway(GO:0034147) negative regulation of toll-like receptor 5 signaling pathway(GO:0034148) negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070429) tolerance induction to lipopolysaccharide(GO:0072573) |
0.3 | 0.8 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.2 | 3.6 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.2 | 1.4 | GO:0009098 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
0.2 | 0.7 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.2 | 1.6 | GO:0014004 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
0.2 | 2.6 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
0.2 | 1.1 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
0.2 | 0.9 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
0.2 | 2.5 | GO:0043312 | neutrophil degranulation(GO:0043312) |
0.2 | 0.8 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.2 | 1.0 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.2 | 1.8 | GO:0060613 | fat pad development(GO:0060613) |
0.2 | 1.4 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.2 | 0.4 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
0.2 | 2.1 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.2 | 1.5 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.2 | 2.9 | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.2 | 1.3 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.2 | 3.1 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.2 | 0.9 | GO:0021564 | vagus nerve development(GO:0021564) |
0.2 | 1.1 | GO:1902965 | regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
0.2 | 0.7 | GO:0014028 | notochord formation(GO:0014028) |
0.2 | 1.4 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.2 | 1.2 | GO:0016266 | O-glycan processing(GO:0016266) |
0.2 | 2.2 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.2 | 0.7 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.2 | 1.7 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.2 | 1.5 | GO:0032725 | positive regulation of granulocyte macrophage colony-stimulating factor production(GO:0032725) |
0.2 | 0.5 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
0.2 | 0.5 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.2 | 0.5 | GO:0019858 | cytosine metabolic process(GO:0019858) |
0.2 | 1.6 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.2 | 1.5 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) |
0.2 | 0.5 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
0.2 | 0.5 | GO:0002644 | negative regulation of tolerance induction(GO:0002644) |
0.2 | 1.7 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.1 | 1.0 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.1 | 0.4 | GO:0001928 | regulation of exocyst assembly(GO:0001928) |
0.1 | 0.6 | GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
0.1 | 2.0 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.1 | 0.3 | GO:0006409 | tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
0.1 | 0.4 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.1 | 2.1 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.1 | 1.5 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.1 | 1.6 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.1 | 1.4 | GO:0046959 | habituation(GO:0046959) |
0.1 | 1.7 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.1 | 0.4 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.1 | 1.2 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.1 | 1.7 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
0.1 | 0.5 | GO:2001168 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
0.1 | 1.3 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.1 | 1.1 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.1 | 1.8 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.1 | 0.4 | GO:0019085 | early viral transcription(GO:0019085) |
0.1 | 2.1 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.1 | 0.5 | GO:1904953 | Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904953) |
0.1 | 0.7 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.1 | 0.9 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.1 | 0.7 | GO:0043201 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.1 | 0.8 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.1 | 0.7 | GO:1903350 | response to dopamine(GO:1903350) cellular response to dopamine(GO:1903351) |
0.1 | 0.6 | GO:0010747 | positive regulation of plasma membrane long-chain fatty acid transport(GO:0010747) |
0.1 | 1.1 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.1 | 0.4 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.1 | 0.8 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.1 | 0.4 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.1 | 0.4 | GO:0046381 | CMP-N-acetylneuraminate metabolic process(GO:0046381) |
0.1 | 0.4 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) retrograde trans-synaptic signaling(GO:0098917) |
0.1 | 0.5 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.1 | 0.9 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.1 | 1.3 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.1 | 0.3 | GO:1905077 | negative regulation of interleukin-17 secretion(GO:1905077) |
0.1 | 1.2 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.1 | 0.4 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.1 | 0.3 | GO:0035574 | histone H4-K20 demethylation(GO:0035574) |
0.1 | 0.9 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.1 | 1.2 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.1 | 0.8 | GO:0042119 | neutrophil activation(GO:0042119) |
0.1 | 0.2 | GO:2000847 | negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.1 | 0.5 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.1 | 2.2 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
0.1 | 0.2 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
0.1 | 0.3 | GO:2000481 | positive regulation of cAMP-dependent protein kinase activity(GO:2000481) |
0.1 | 1.1 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.1 | 0.3 | GO:0010980 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.1 | 0.8 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.1 | 0.6 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.1 | 5.1 | GO:0001541 | ovarian follicle development(GO:0001541) |
0.1 | 0.3 | GO:2000002 | negative regulation of DNA damage checkpoint(GO:2000002) |
0.1 | 0.1 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) Sertoli cell proliferation(GO:0060011) |
0.1 | 0.5 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
0.1 | 2.1 | GO:0007099 | centriole replication(GO:0007099) |
0.1 | 0.3 | GO:0046351 | disaccharide biosynthetic process(GO:0046351) |
0.1 | 0.5 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.1 | 1.3 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.1 | 2.0 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.1 | 1.0 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.1 | 0.4 | GO:0071698 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.1 | 0.7 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
0.1 | 0.4 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.1 | 1.1 | GO:0060307 | regulation of ventricular cardiac muscle cell membrane repolarization(GO:0060307) |
0.1 | 0.2 | GO:0090285 | negative regulation of protein glycosylation in Golgi(GO:0090285) |
0.1 | 0.6 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.1 | 0.3 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.1 | 2.6 | GO:0006414 | translational elongation(GO:0006414) |
0.1 | 1.3 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.1 | 3.9 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.1 | 0.3 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.0 | 0.3 | GO:0032439 | endosome localization(GO:0032439) positive regulation of pinocytosis(GO:0048549) |
0.0 | 0.5 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.0 | 0.8 | GO:0043278 | response to morphine(GO:0043278) |
0.0 | 0.4 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.0 | 1.3 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.0 | 1.4 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.0 | 2.6 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.0 | 1.3 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.0 | 2.2 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
0.0 | 0.1 | GO:1990859 | cellular response to endothelin(GO:1990859) |
0.0 | 0.6 | GO:0016926 | protein desumoylation(GO:0016926) |
0.0 | 0.2 | GO:1904627 | response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
0.0 | 0.1 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
0.0 | 2.6 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.0 | 0.2 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.0 | 2.0 | GO:0090307 | mitotic spindle assembly(GO:0090307) |
0.0 | 1.3 | GO:0009409 | response to cold(GO:0009409) |
0.0 | 3.0 | GO:0042157 | lipoprotein metabolic process(GO:0042157) |
0.0 | 0.6 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.0 | 0.8 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.0 | 0.1 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) |
0.0 | 0.1 | GO:0046021 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) axial mesoderm morphogenesis(GO:0048319) |
0.0 | 1.1 | GO:0002931 | response to ischemia(GO:0002931) |
0.0 | 1.8 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.0 | 0.8 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.0 | 0.8 | GO:0003334 | keratinocyte development(GO:0003334) |
0.0 | 0.2 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.0 | 1.9 | GO:0042058 | regulation of epidermal growth factor receptor signaling pathway(GO:0042058) |
0.0 | 1.0 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.0 | 1.7 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.0 | 0.2 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.0 | 0.1 | GO:2000412 | lymphocyte migration into lymphoid organs(GO:0097021) positive regulation of thymocyte migration(GO:2000412) regulation of dendritic cell dendrite assembly(GO:2000547) |
0.0 | 0.4 | GO:1904672 | regulation of somatic stem cell population maintenance(GO:1904672) |
0.0 | 0.9 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.0 | 0.7 | GO:0043687 | post-translational protein modification(GO:0043687) |
0.0 | 0.4 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.0 | 1.2 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.0 | 0.2 | GO:0001842 | neural fold formation(GO:0001842) |
0.0 | 1.6 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.0 | 5.4 | GO:0001666 | response to hypoxia(GO:0001666) |
0.0 | 1.0 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.0 | 1.4 | GO:0006284 | base-excision repair(GO:0006284) |
0.0 | 0.3 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.0 | 0.5 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.0 | 0.3 | GO:0051451 | myoblast migration(GO:0051451) |
0.0 | 0.1 | GO:0072362 | regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072362) |
0.0 | 0.2 | GO:2000400 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.0 | 0.9 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
0.0 | 2.7 | GO:0051028 | mRNA transport(GO:0051028) |
0.0 | 0.4 | GO:0035563 | regulation of chromatin binding(GO:0035561) positive regulation of chromatin binding(GO:0035563) |
0.0 | 0.3 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.0 | 0.2 | GO:0050862 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.0 | 0.2 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.0 | 0.1 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.0 | 0.2 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.0 | 0.1 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
0.0 | 0.1 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.0 | 0.1 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
0.0 | 0.3 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.0 | 1.4 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.0 | 0.2 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) |
0.0 | 0.3 | GO:0006907 | pinocytosis(GO:0006907) |
0.0 | 1.5 | GO:0007030 | Golgi organization(GO:0007030) |
0.0 | 0.2 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.0 | 0.3 | GO:0021535 | cell migration in hindbrain(GO:0021535) |
0.0 | 1.4 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.1 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.0 | 0.0 | GO:0072734 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
0.0 | 0.0 | GO:0060439 | lung growth(GO:0060437) trachea morphogenesis(GO:0060439) trachea cartilage morphogenesis(GO:0060535) |
0.0 | 1.9 | GO:0002244 | hematopoietic progenitor cell differentiation(GO:0002244) |
0.0 | 0.3 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.0 | 1.6 | GO:0098656 | anion transmembrane transport(GO:0098656) |
0.0 | 0.2 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.0 | 0.2 | GO:0006337 | nucleosome disassembly(GO:0006337) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 4.1 | GO:1990257 | piccolo-bassoon transport vesicle(GO:1990257) |
1.1 | 6.3 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.9 | 2.7 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.6 | 5.8 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.6 | 2.2 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
0.4 | 2.1 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.4 | 1.2 | GO:0005584 | collagen type I trimer(GO:0005584) |
0.3 | 2.1 | GO:0098536 | deuterosome(GO:0098536) |
0.3 | 1.2 | GO:0060187 | cell pole(GO:0060187) |
0.2 | 0.7 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.2 | 2.0 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.2 | 4.4 | GO:0051286 | cell tip(GO:0051286) |
0.2 | 1.8 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.2 | 0.7 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.2 | 1.3 | GO:0001940 | male pronucleus(GO:0001940) |
0.2 | 2.6 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.1 | 1.3 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) RISC-loading complex(GO:0070578) |
0.1 | 0.9 | GO:0005955 | calcineurin complex(GO:0005955) |
0.1 | 0.6 | GO:0098888 | extrinsic component of presynaptic membrane(GO:0098888) |
0.1 | 4.5 | GO:0097228 | sperm principal piece(GO:0097228) |
0.1 | 1.3 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 0.7 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.1 | 1.9 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.1 | 1.8 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.1 | 0.8 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.1 | 0.9 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.1 | 0.8 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 1.1 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.1 | 0.3 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.1 | 0.6 | GO:0044308 | axonal spine(GO:0044308) |
0.1 | 1.1 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.1 | 0.4 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.1 | 1.4 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 1.3 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.1 | 1.5 | GO:0032433 | filopodium tip(GO:0032433) |
0.1 | 1.2 | GO:0036038 | MKS complex(GO:0036038) |
0.1 | 1.5 | GO:0010369 | chromocenter(GO:0010369) |
0.1 | 1.8 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.1 | 6.4 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 0.5 | GO:0033503 | HULC complex(GO:0033503) |
0.1 | 4.6 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 0.6 | GO:0071439 | clathrin complex(GO:0071439) |
0.1 | 0.4 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.1 | 0.3 | GO:0071204 | U7 snRNP(GO:0005683) histone pre-mRNA 3'end processing complex(GO:0071204) |
0.1 | 0.4 | GO:0097422 | tubular endosome(GO:0097422) |
0.1 | 2.4 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.1 | 0.8 | GO:0032039 | integrator complex(GO:0032039) |
0.0 | 0.3 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.0 | 0.5 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
0.0 | 1.7 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.0 | 1.2 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.0 | 0.3 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.0 | 8.3 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.0 | 0.2 | GO:0090537 | CERF complex(GO:0090537) |
0.0 | 2.7 | GO:0005871 | kinesin complex(GO:0005871) |
0.0 | 2.6 | GO:0031941 | filamentous actin(GO:0031941) |
0.0 | 0.3 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.0 | 3.7 | GO:0005814 | centriole(GO:0005814) |
0.0 | 4.7 | GO:0000792 | heterochromatin(GO:0000792) |
0.0 | 2.9 | GO:0072686 | mitotic spindle(GO:0072686) |
0.0 | 2.9 | GO:0005643 | nuclear pore(GO:0005643) |
0.0 | 0.5 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.0 | 0.4 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.0 | 0.9 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.0 | 1.0 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.0 | 0.1 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.0 | 1.8 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.0 | 1.0 | GO:0016363 | nuclear matrix(GO:0016363) |
0.0 | 0.3 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.0 | 0.3 | GO:0005685 | U1 snRNP(GO:0005685) |
0.0 | 0.3 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.0 | 1.9 | GO:0036126 | sperm flagellum(GO:0036126) |
0.0 | 3.5 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.0 | 2.2 | GO:0005901 | caveola(GO:0005901) |
0.0 | 1.1 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 6.8 | GO:0016607 | nuclear speck(GO:0016607) |
0.0 | 0.1 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.0 | 0.2 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.0 | 0.6 | GO:0002102 | podosome(GO:0002102) |
0.0 | 4.6 | GO:0005769 | early endosome(GO:0005769) |
0.0 | 0.3 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.0 | 1.3 | GO:0016605 | PML body(GO:0016605) |
0.0 | 0.2 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.0 | 4.2 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 1.3 | GO:0014704 | intercalated disc(GO:0014704) |
0.0 | 0.5 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.0 | 0.3 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.0 | 2.1 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.0 | 0.5 | GO:0016460 | myosin II complex(GO:0016460) |
0.0 | 0.1 | GO:0070545 | PeBoW complex(GO:0070545) |
0.0 | 0.2 | GO:0001891 | phagocytic cup(GO:0001891) |
0.0 | 0.1 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 0.2 | GO:0001741 | XY body(GO:0001741) |
0.0 | 2.1 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.0 | 3.1 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.0 | 5.1 | GO:0031966 | mitochondrial membrane(GO:0031966) |
0.0 | 0.8 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 0.2 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 4.2 | GO:0000785 | chromatin(GO:0000785) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 5.8 | GO:0070052 | collagen V binding(GO:0070052) |
1.0 | 5.1 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.9 | 2.8 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.9 | 3.7 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
0.9 | 3.6 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.9 | 2.6 | GO:0004686 | elongation factor-2 kinase activity(GO:0004686) |
0.6 | 1.7 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.5 | 10.0 | GO:0035198 | miRNA binding(GO:0035198) |
0.5 | 2.0 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.5 | 12.8 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.5 | 1.8 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.4 | 1.3 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.4 | 2.1 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.4 | 3.3 | GO:0030911 | TPR domain binding(GO:0030911) |
0.4 | 4.8 | GO:0015217 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
0.4 | 3.0 | GO:0043559 | insulin binding(GO:0043559) |
0.3 | 2.4 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.3 | 1.7 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.3 | 1.7 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.3 | 2.6 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.3 | 1.3 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
0.3 | 2.9 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.3 | 1.8 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.3 | 2.6 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.3 | 1.4 | GO:1904047 | S-adenosyl-L-methionine binding(GO:1904047) |
0.3 | 0.8 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.3 | 3.5 | GO:0003680 | AT DNA binding(GO:0003680) |
0.2 | 1.4 | GO:0052655 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
0.2 | 3.2 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.2 | 1.6 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.2 | 1.5 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.2 | 1.5 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.2 | 0.9 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.2 | 1.4 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.2 | 4.0 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.2 | 1.5 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.2 | 2.3 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.2 | 2.3 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.2 | 1.8 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.2 | 1.0 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.2 | 1.1 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.2 | 2.3 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.1 | 0.3 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.1 | 0.7 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
0.1 | 1.1 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 0.4 | GO:0030338 | CMP-N-acetylneuraminate monooxygenase activity(GO:0030338) |
0.1 | 1.5 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.1 | 0.4 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.1 | 0.4 | GO:0004915 | interleukin-6 receptor activity(GO:0004915) interleukin-6 binding(GO:0019981) |
0.1 | 0.4 | GO:0034437 | glycoprotein transporter activity(GO:0034437) |
0.1 | 1.2 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 0.9 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 0.5 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.1 | 1.5 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.1 | 0.8 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.1 | 1.1 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.1 | 0.3 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.1 | 1.0 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.1 | 0.3 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.1 | 1.3 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.1 | 2.4 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 0.3 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.1 | 2.6 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 1.5 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 0.3 | GO:0035575 | histone demethylase activity (H4-K20 specific)(GO:0035575) |
0.1 | 0.3 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.1 | 0.5 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.1 | 1.0 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.1 | 1.8 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 3.3 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
0.1 | 0.7 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.1 | 0.6 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.1 | 0.2 | GO:0098770 | FBXO family protein binding(GO:0098770) |
0.1 | 0.4 | GO:0089720 | caspase binding(GO:0089720) |
0.1 | 0.8 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 1.2 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.1 | 5.8 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.1 | 1.9 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.1 | 15.2 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.1 | 0.2 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.1 | 0.4 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.1 | 0.3 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.1 | 0.8 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 0.2 | GO:0071633 | dihydroceramidase activity(GO:0071633) |
0.1 | 0.5 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.1 | 0.9 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.1 | 0.3 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.1 | 0.1 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.1 | 1.1 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 1.1 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.0 | 0.7 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 0.7 | GO:0048185 | activin binding(GO:0048185) |
0.0 | 4.9 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.0 | 2.6 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.0 | 5.2 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 1.1 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.4 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.0 | 0.1 | GO:0004822 | isoleucine-tRNA ligase activity(GO:0004822) |
0.0 | 0.3 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.0 | 0.5 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 0.4 | GO:0035197 | siRNA binding(GO:0035197) |
0.0 | 0.4 | GO:0034452 | dynactin binding(GO:0034452) |
0.0 | 0.2 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.0 | 0.6 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.0 | 0.9 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.0 | 1.1 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.0 | 0.5 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.0 | 3.6 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
0.0 | 1.5 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.0 | 0.8 | GO:0048156 | tau protein binding(GO:0048156) |
0.0 | 0.4 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.0 | 0.6 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.0 | 0.8 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.0 | 6.4 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.0 | 0.6 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.0 | 1.5 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 0.7 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.0 | 0.7 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.0 | 0.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.0 | 1.4 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.2 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.0 | 1.1 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.0 | 1.0 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.0 | 2.7 | GO:0004620 | phospholipase activity(GO:0004620) |
0.0 | 1.3 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.0 | 1.5 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.0 | 1.7 | GO:0003724 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) |
0.0 | 0.2 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.0 | 1.4 | GO:0098811 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.0 | 0.3 | GO:0043495 | protein anchor(GO:0043495) |
0.0 | 1.3 | GO:0003774 | motor activity(GO:0003774) |
0.0 | 0.5 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 1.4 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.0 | 0.2 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.0 | 1.2 | GO:0015485 | cholesterol binding(GO:0015485) |
0.0 | 0.2 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.0 | 0.3 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.0 | 1.1 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.0 | 2.5 | GO:0001047 | core promoter binding(GO:0001047) |
0.0 | 0.3 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.0 | 0.1 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.0 | 0.1 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.0 | 0.3 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.0 | 0.0 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.0 | 0.6 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.0 | 0.3 | GO:0005402 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) |
0.0 | 0.2 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) |
0.0 | 0.3 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.0 | 0.6 | GO:0003743 | translation initiation factor activity(GO:0003743) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 8.4 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.3 | 4.6 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.1 | 2.6 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 1.3 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 5.9 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 12.7 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 12.8 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 1.9 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.1 | 4.5 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 4.2 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 1.2 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.1 | 2.1 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 1.5 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 1.4 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.1 | 4.3 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.1 | 1.6 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 3.3 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 2.7 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.1 | 3.0 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.1 | 0.9 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 1.2 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.1 | 2.2 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 0.8 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 2.0 | PID PLK1 PATHWAY | PLK1 signaling events |
0.0 | 2.3 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 1.0 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 4.9 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.9 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.9 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 1.3 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.0 | 1.7 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 2.2 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 0.8 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.0 | 1.5 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 0.6 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 1.1 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 0.4 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.9 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 0.2 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 0.4 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.5 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 0.3 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 0.1 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.0 | 0.7 | PID CMYB PATHWAY | C-MYB transcription factor network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 5.2 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.4 | 1.3 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.4 | 8.3 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.3 | 5.1 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.2 | 2.0 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.2 | 5.1 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.2 | 2.6 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.1 | 2.1 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.1 | 4.1 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.1 | 4.4 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.1 | 2.6 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 2.3 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 2.0 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.1 | 3.6 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 2.2 | REACTOME KINESINS | Genes involved in Kinesins |
0.1 | 1.5 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.1 | 1.2 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 2.7 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.1 | 4.3 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 1.5 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.1 | 9.1 | REACTOME DIABETES PATHWAYS | Genes involved in Diabetes pathways |
0.1 | 1.0 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.1 | 1.8 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.1 | 1.0 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.1 | 0.5 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.1 | 1.1 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.1 | 1.1 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.1 | 1.6 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 5.9 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 1.2 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 1.5 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.1 | 2.6 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.4 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.0 | 1.5 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
0.0 | 2.2 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 1.3 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.0 | 1.5 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 1.1 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 3.1 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.0 | 2.3 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.0 | 0.2 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 1.3 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.0 | 2.9 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.0 | 1.0 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.0 | 1.1 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.0 | 0.8 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 0.9 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.0 | 1.0 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 0.7 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.0 | 0.3 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 0.3 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.0 | 0.4 | REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA | Genes involved in Processing of Capped Intronless Pre-mRNA |
0.0 | 1.4 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.0 | 0.4 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.0 | 0.4 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.0 | 0.5 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.0 | 0.2 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.0 | 1.6 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.0 | 0.1 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.0 | 0.3 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |